Related references
Note: Only part of the references are listed.CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model
Partha Mukhopadhyay et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes
Partha Mukhopadhyay et al.
CARDIOVASCULAR RESEARCH (2010)
Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy
Partha Mukhopadhyay et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor-Deficient Mice
Frederique Dol-Gleizes et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Cannabinoid CB1 Receptor Antagonists for Atherosclerosis and Cardiometabolic Disorders New Hopes, Old Concerns?
Pal Pacher
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction
Shiang Y. Lim et al.
BASIC RESEARCH IN CARDIOLOGY (2009)
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Roger G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction
Csaba Szabo
BRITISH JOURNAL OF PHARMACOLOGY (2009)
CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages
Ki Hoon Han et al.
CARDIOVASCULAR RESEARCH (2009)
Activated Endocannabinoid System in Coronary Artery Disease and Antiinflammatory Effects of Cannabinoid 1 Receptor Blockade on Macrophages
Koichi Sugamura et al.
CIRCULATION (2009)
Endothelial Dysfunction - The First Step Toward Coronary Arteriosclerosis
Paul M. Vanhoutte
CIRCULATION JOURNAL (2009)
Signal Transduction via Cannabinoid Receptors
George D. Dalton et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia
P. Caraceni et al.
GUT (2009)
Endocannabinoids and the Heart
C. Robin Hiley
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke
Ming Zhang et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2009)
CENTRAL CANNABINOID 1 RECEPTOR ANTAGONIST ADMINISTRATION PREVENTS ENDOTOXIC HYPOTENSION AFFECTING NOREPINEPHRINE RELEASE IN THE PREOPTIC ANTERIOR HYPOTHALAMIC AREA
Alex Villanueva et al.
SHOCK (2009)
Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation
Mohanraj Rajesh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration
M. Rajesh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning
P. Pacher et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Cannabinoid receptors in acute and chronic complications of atherosclerosis
F. Mach et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Guide to receptors and channels (GRAC), 3rd edition
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Cannabinoid Receptors as Therapeutic Targets in the Management of Liver Diseases
Ariane Mallat et al.
DRUG NEWS & PERSPECTIVES (2008)
Inflammation and endothelial dysfunction during aging: role of NF-kappa B
Anna Csiszar et al.
JOURNAL OF APPLIED PHYSIOLOGY (2008)
Dysregulation of the endocannabinoid system in obesity
S. Engeli
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Targeting the endocannabinoid system: to enhance or reduce?
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2008)
Cannabinoids as therapeutic agents in cardiovascular disease:: a tale of passions and illusions
V. E. Mendizabal et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats
P. Janiak et al.
KIDNEY INTERNATIONAL (2007)
CB2-receptor stimulation attenuates TNF-α-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion
Mohanraj Rajesh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Pharmacological inhibition of CB1 cannabinoid raceptor protects against doxorubicin-induced cardiotoxicity
Partha Mukhopadhyay et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall
Ravi M. Rao et al.
CIRCULATION RESEARCH (2007)
Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats
Magali Gary-Bobo et al.
HEPATOLOGY (2007)
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
Sandor Batkai et al.
FASEB JOURNAL (2007)
Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy
Partha Mukhopadhyay et al.
NATURE PROTOCOLS (2007)
Nitric oxide and peroxynitrite in health and disease
Pal Pacher et al.
PHYSIOLOGICAL REVIEWS (2007)
Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra
Clemens Sommer et al.
ACTA NEUROPATHOLOGICA (2006)
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Fatima Teixeira-Clerc et al.
NATURE MEDICINE (2006)
Cytokines in atherosclerosis: Pathogenic and regulatory pathways
A Tedgui et al.
PHYSIOLOGICAL REVIEWS (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Cannabinoid antagonist AM 281 reduces mortality rate and neurologic dysfunction after cecal ligation and puncture in rats
Y Kadoi et al.
CRITICAL CARE MEDICINE (2005)
Effects of AM281, a cannabinoid antagonist, on systemic haemodynamics, internal carotid artery blood flow and mortality in septic shock in rats
Y Kadoi et al.
BRITISH JOURNAL OF ANAESTHESIA (2005)
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
S Steffens et al.
NATURE (2005)
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
B Julien et al.
GASTROENTEROLOGY (2005)
Massive accumulation of N-acylethanolamines after stroke.: Cell signalling in acute cerebral ischemia?
C Berger et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Anandamide content is increased and Cb-1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia
S Muthian et al.
NEUROSCIENCE (2004)
Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle
A Bonz et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
NAD(P)H oxidase - Role in cardiovascular biology and disease
KK Griendling et al.
CIRCULATION RESEARCH (2000)
Share Paper
